Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.050
+0.090 (4.59%)
At close: Jul 30, 2025, 4:00 PM
2.070
+0.020 (0.98%)
After-hours: Jul 30, 2025, 7:04 PM EDT

Caribou Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
9.929.9934.4813.859.612.36
Upgrade
Revenue Growth (YoY)
-70.31%-71.01%148.91%44.31%-22.35%113.56%
Upgrade
Cost of Revenue
129.68129.55112.0882.2352.2634.43
Upgrade
Gross Profit
-119.76-119.56-77.6-68.38-42.66-22.06
Upgrade
Selling, General & Admin
37.6542.5638.4638.0224.3214.06
Upgrade
Operating Expenses
39.2742.5638.4638.0224.3214.06
Upgrade
Operating Income
-159.03-162.12-116.06-106.4-66.98-36.12
Upgrade
Interest Expense
------0.02
Upgrade
Interest & Investment Income
13.4215.315.3--0.24
Upgrade
Other Non Operating Income (Expenses)
2.232.2-1.127.18-1.210.51
Upgrade
EBT Excluding Unusual Items
-143.37-144.61-101.88-99.22-68.19-35.39
Upgrade
Merger & Restructuring Charges
-0.6-0.6----
Upgrade
Gain (Loss) on Sale of Investments
----0.13--0.73
Upgrade
Legal Settlements
-3.9-3.9----
Upgrade
Other Unusual Items
----1.58-
Upgrade
Pretax Income
-147.87-149.11-101.88-99.35-66.6-36.13
Upgrade
Income Tax Expense
-0.01-0.010.190.070.32-1.82
Upgrade
Net Income
-147.86-149.11-102.07-99.42-66.92-34.31
Upgrade
Net Income to Common
-147.86-149.11-102.07-99.42-66.92-34.31
Upgrade
Shares Outstanding (Basic)
91907461329
Upgrade
Shares Outstanding (Diluted)
91907461329
Upgrade
Shares Change (YoY)
12.77%22.37%21.39%92.02%270.47%2.05%
Upgrade
EPS (Basic)
-1.62-1.65-1.38-1.64-2.11-4.01
Upgrade
EPS (Diluted)
-1.62-1.65-1.38-1.64-2.11-4.01
Upgrade
Free Cash Flow
-142.2-143.08-104.9-97.42-34.64-33.53
Upgrade
Free Cash Flow Per Share
-1.56-1.58-1.42-1.60-1.09-3.92
Upgrade
Gross Margin
---225.07%---178.50%
Upgrade
Operating Margin
-1603.42%-1622.13%-336.63%-768.17%-697.84%-292.24%
Upgrade
Profit Margin
-1490.85%-1491.94%-296.05%-717.79%-697.26%-277.55%
Upgrade
Free Cash Flow Margin
-1433.72%-1431.66%-304.27%-703.34%-360.91%-271.27%
Upgrade
EBITDA
-154.65-158.19-112.53-104.78-66-35.22
Upgrade
EBITDA Margin
------284.96%
Upgrade
D&A For EBITDA
4.383.933.531.620.980.9
Upgrade
EBIT
-159.03-162.12-116.06-106.4-66.98-36.12
Upgrade
EBIT Margin
------292.24%
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q